Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Savelieva

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Clinical Medicine (London, England)|September 22, 2007
Atrial fibrillation--all change!Irina Savelieva, John Camm
Clinical Cardiology|February 8, 2008
Update on atrial fibrillation: part IIrina Savelieva, John Camm
American Heart Journal|August 28, 2007
Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?Irina Savelieva, John Camm
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 3, 2008
Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approachesIrina Savelieva, John Camm
Nature Clinical Practice. Cardiovascular Medicine|December 21, 2007
Statins and polyunsaturated fatty acids for treatment of atrial fibrillationIrina Savelieva, John Camm
Clinical Cardiology|April 3, 2008
Update on atrial fibrillation: part IIIrina Savelieva, John Camm
European Heart Journal|September 2, 2014
Vagal nerve stimulation in heart failureA John Camm, Irina Savelieva
Cardiology|November 13, 2019
A New Biomarker in Atrial Fibrillation: Monocyte Chemoattractant Protein-1-Induced ProteinIrina Savelieva, A John Camm
Heart Rhythm|April 27, 2005
Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now?A John Camm, Irina Savelieva
Circulation|September 9, 2011
Fish oil for secondary prevention of atrial fibrillation: should we still believe in its antiarrhythmic effect?A John Camm, Irina Savelieva
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Clinical Medicine (London, England)|September 22, 2007
Atrial fibrillation--all change!Irina Savelieva, John Camm
Clinical Cardiology|February 8, 2008
Update on atrial fibrillation: part IIrina Savelieva, John Camm
American Heart Journal|August 28, 2007
Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?Irina Savelieva, John Camm
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 3, 2008
Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approachesIrina Savelieva, John Camm
Nature Clinical Practice. Cardiovascular Medicine|December 21, 2007
Statins and polyunsaturated fatty acids for treatment of atrial fibrillationIrina Savelieva, John Camm
Clinical Cardiology|April 3, 2008
Update on atrial fibrillation: part IIIrina Savelieva, John Camm
European Heart Journal|September 2, 2014
Vagal nerve stimulation in heart failureA John Camm, Irina Savelieva
Cardiology|November 13, 2019
A New Biomarker in Atrial Fibrillation: Monocyte Chemoattractant Protein-1-Induced ProteinIrina Savelieva, A John Camm
Heart Rhythm|April 27, 2005
Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now?A John Camm, Irina Savelieva
Circulation|September 9, 2011
Fish oil for secondary prevention of atrial fibrillation: should we still believe in its antiarrhythmic effect?A John Camm, Irina Savelieva
Pageof 7